Off-the-shelf models like AlphaFold or ESM provide general predictions. Fine-tuning adapts them to your proprietary data, delivering domain-specific accuracy improvements of 15-40% on your most critical tasks.
Architecture review before implementation
Implementation scope and rollout planning
Clear next-step recommendation
Specialize foundation models for your specific organism, disease, or experimental context to achieve lab-validated accuracy.
Off-the-shelf models like AlphaFold or ESM provide general predictions. Fine-tuning adapts them to your proprietary data, delivering domain-specific accuracy improvements of 15-40% on your most critical tasks.
We transform generic AI into a proprietary asset, trained on your unique biological context to drive faster, more reliable R&D decisions.
CRISPR screens, HTS).Our fine-tuning service transforms raw biological data into predictive models that deliver measurable, reproducible results in the lab. We focus on outcomes that directly accelerate your R&D timeline and de-risk development.
Fine-tune pre-trained models (ESM, AlphaFold) on your proprietary data to predict viable candidates with higher precision, reducing costly wet-lab screening cycles by 40-60%.
Achieve lab-validated accuracy for your specific organism, pathway, or disease context. Move from general biological understanding to targeted, actionable predictions for your research program.
Deploy a production-ready, fine-tuned model within 4-6 weeks. Our MLOps pipeline ensures rapid iteration from data ingestion to validated model output, compressing discovery timelines.
Seamlessly connect fine-tuned models to your internal data lakes, electronic lab notebooks (ELNs), and high-throughput screening systems via robust APIs, avoiding disruptive platform changes.
Receive not just predictions, but model confidence scores and interpretable features (e.g., attention maps on protein sequences). This builds scientific trust and guides experimental design.
A transparent breakdown of our phased engagement model for fine-tuning computational biology models, from initial data alignment to final validation and deployment.
| Phase & Deliverables | Starter (Proof-of-Concept) | Professional (Production-Ready) | Enterprise (Full Pipeline) |
|---|---|---|---|
Project Kickoff & Data Assessment | |||
Custom Data Pipeline & Featurization | Basic preprocessing | Advanced multimodal fusion | End-to-end MLOps pipeline |
Model Selection & Architecture Design | Single pre-trained model (e.g., ESM-2) | Multi-model ensemble or custom GNN | Proprietary foundation model adaptation |
Fine-Tuning & Validation Cycles | 1-2 cycles on target dataset | 3-5 cycles with cross-validation | Continuous active learning loop |
Benchmarking & Performance Report | Accuracy vs. baseline | Comprehensive metrics (AUC, F1, RMSE) | Lab correlation study & validation report |
Deployment Package | Inference API endpoint | Containerized model + monitoring | Integrated into client's Bio-AI data pipeline |
Ongoing Support & Model Updates | 30-day bug fix window | 6-month SLA with quarterly retuning | Dedicated team for continuous improvement |
Typical Timeline | 4-6 weeks | 8-12 weeks | 12+ weeks (ongoing) |
Starting Investment | From $25K | From $75K | Custom quote |
We execute a rigorous, multi-phase adaptation of pre-trained biological AI models to your specific organism, disease, or experimental context. Our process is designed to deliver models with validated, high-accuracy performance for your R&D pipeline.
Enabling Efficiency, Speed & Accuracy
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Get specific answers on timelines, costs, and technical approaches for fine-tuning biological AI models to your proprietary data.
Standard projects for adapting models like ESM or AlphaFold to a specific organism or disease target take 4-8 weeks from kickoff to validated model delivery. This includes data preprocessing, iterative fine-tuning, and initial performance benchmarking. Complex multi-modal integrations (e.g., combining omics with imaging) may extend to 12 weeks. We provide a detailed, phase-gated project plan at engagement start.

About the author
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
How We Work
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
The first call is a practical review of your use case and the right next step.